Company
Trevi Therapeutics
Trevi Therapeutics has 1 drug tracked on RxWires: 1 in Phase 3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| NAL ER | Phase 3 | Idiopathic Pulmonary Fibrosis |
Latest
No recent events.
Follow Trevi Therapeutics on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.